Handelsavisen
prelaunch
Companies Healthcare 4735.TWO
47
4735.TWO TPEx Medical Equipment, Supplies & Distribution

Avita Corp

$30,75
Open in Charts → Attach watcher ⌖
TWD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,2B TWD
P/E
12,8x
EV / Rev
1,4x
Div yield
6,66 %
Op margin
-15,6 %
ROE
-0,6 %
Net margin
-2,8 %
Debt / equity
0,16
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Avita Corp operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to the market.

Business. Avita Corp (4735.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Avita Corp is listed on the Taiwan Premium Exchange (TPEx).

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
12,8x
P/E
Analysts
not yet wired
Ownership
not yet wired
Profitability
-0,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 4735.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 4735.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Avita Corp (4735.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Avita Corp is listed on the Taiwan Premium Exchange (TPEx).

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Avita Corp's capital structure is characterized by a market price of $31.00 per share and a market capitalization of $1.19 billion, with a price-to-book ratio of 1.35 and a price-to-tangible-book ratio of 1.35. The company's liquidity position is assessed as medium, with a current ratio of 1.94 and a debt-to-equity ratio of 0.16, indicating a relatively conservative leverage profile. However, the company's enterprise value to EBITDA ratio is negative at -43.89, reflecting a loss-making position in the most recent period.

    Profitability metrics show a challenging performance, with a return on equity of -0.62% and a return on assets of -0.41%, both significantly below the industry median for medical equipment and supplies firms. The company reported a net loss of $5.51 million and an operating loss of $30.48 million, with a gross profit of $31.92 million on total revenue of $195.11 million. These figures suggest a need for operational improvements to achieve profitability.

    Avita Corp's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial data. This lack of diversification may expose the company to higher risk in the event of regional or sector-specific downturns. The company's capital expenditures were -$2.33 million, indicating a reduction in investment in physical assets.

    Looking ahead, Avita Corp's growth trajectory is uncertain, with no disclosed revenue growth in the most recent period. The company's free cash flow was $9.18 million, while its operating cash flow was negative at -$25.51 million. These mixed cash flow signals suggest a need for careful management of working capital and cost structures to support future growth.

    Risk factors for Avita Corp include a medium liquidity risk, with a current ratio of 1.94 and a debt-to-equity ratio of 0.16. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. However, the company's net cash position is negative after subtracting total debt, which could impact its ability to fund operations or invest in growth opportunities.

    Recent events for Avita Corp include the latest financial filing, which shows a net loss and a negative operating cash flow. No recent earnings call transcripts or other disclosures were available in the provided data, limiting insight into management's strategic direction or operational updates.

    Key takeaways
    • Avita Corp is operating at a loss, with a net income of -$5.51 million and an operating income of -$30.48 million.
    • The company's liquidity position is medium, with a current ratio of 1.94 and a debt-to-equity ratio of 0.16.
    • Avita Corp's profitability metrics are below industry medians, with a return on equity of -0.62% and a return on assets of -0.41%.
    • The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • Avita Corp's free cash flow was $9.18 million, while its operating cash flow was negative at -$25.51 million.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Net income surged 61% year-over-year to TWD 93.2 million, demonstrating significant recent profitability improvement.

    Operating income jumped 197.5% year-over-year, indicating a strong recovery in core operational efficiency.

    Cash conversion ratio of 4.63 ranks best-in-class among 331 peers, highlighting superior cash generation.

    Debt-to-equity ratio of 0.16 is below the cohort median of 0.2, suggesting a conservative capital structure.

    Dilution risk is assessed as low, providing reassurance to existing shareholders regarding equity value preservation.

    BEAR CASE · 2

    Credit risk is flagged as high, indicating significant potential for financial distress or default issues.

    Return on equity of -0.62% lags the cohort median of 1.42%, indicating inefficient use of shareholder capital.

    In focus — financials by report

    Annual
    ANNUALFiled 2023-03-17
    FY 2023 · Full-year highlights

    Revenue TWD 1.20B, −48,4% YoY; Operating income −70,2% YoY.

    RevenueTWD 1.20B−48,4 % YoY
    Operating incomeTWD 116.5M−70,2 % YoY
    Net incomeTWD 101.1M−67,9 % YoY
    Free cash flowTWD 12.6M−25,6 % YoY
    EPS
    Operating cash flowTWD 490.5M+107,0 % YoY
    Financials
    Income statement
    RevenueTWD 1.20B
    Gross profitTWD 356.8M
    Operating incomeTWD 116.5M
    Net incomeTWD 101.1M
    Margins
    Gross margin29.7%
    Operating margin9.7%
    Net margin8.4%
    FCF margin1.0%
    Balance sheet
    Total assetsTWD 1.34B
    Total liabilitiesTWD 426.6M
    Total equityTWD 911.2M
    Cash & equivalents
    Long-term debtTWD 74.4M
    Cash flow
    Operating cash flowTWD 490.5M
    CapEx-TWD 65.3M
    Free cash flowTWD 12.6M
    SBC
    P&L flow · revenue → net income
    Revenue TWD 195.1MOperating costs TWD 225.6MFinance TWD 939.0kNet income TWD 5.5M
    Highlights
    • Revenue TWD 1.20B, −48,4% YoY
    • Operating income −70,2% YoY
    • Net income −67,9% YoY
    • Free cash flow −25,6% YoY
    • Net margin 8.4%

    Valuation FY

    Market price
    $30,75
    Market cap
    $1.19B
    Enterprise value
    $1.34B
    P/E
    12.8x
    Non-GAAP P/E
    EV / Revenue
    1.4x
    EV / Op income
    28.9x
    EV / OCF
    P / B
    1.4x
    P / Tangible book
    1.4x
    Tangible book
    $881.6M
    Net cash
    -$144.3M
    Current ratio
    1.9
    Debt / equity
    0.2
    ROA
    -0.4%
    ROE
    -0.6%
    Cash conversion
    463.0%
    CapEx / revenue
    -1.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-15,6 %Below median
    Net Margin-2,8 %Below median
    ROE-0,6 %Below median
    Capex / Rev-1,2 %Above P75
    D/E0,16Above median
    Cash Conv4,63Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • Avita Corp Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    4735.TWOCanonical
    TPEx · TWD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2023-03-17 14:16 UTCEARNINGSAnnual results — FY 2023 Revenue TWD 1.20B · Net TWD 101.1M
    2022-03-18 17:06 UTCEARNINGSAnnual results — FY 2022 Revenue TWD 2.33B · Net TWD 315.5M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage